704
Participants
Start Date
July 31, 2004
Primary Completion Date
October 31, 2005
Study Completion Date
October 31, 2005
Pioglitazone and azilsartan
Pioglitazone 15 mg, tablets, orally, once daily and azilsartan 5 mg, tablets, orally, once daily for up to 24 weeks.
Pioglitazone and azilsartan
Pioglitazone 15 mg, tablets, orally, once daily and azilsartan 40 mg, tablets, orally, once daily for up to 24 weeks.
Pioglitazone
Pioglitazone 15 mg, tablets, orally, once daily and azilsartan placebo-matching tablets, orally, once daily for up to 24 weeks.
Pioglitazone and azilsartan
Pioglitazone 45 mg, tablets, orally, once daily and azilsartan 5 mg, tablets, orally, once daily for up to 24 weeks.
Pioglitazone and azilsartan
Pioglitazone 45 mg, tablets, orally, once daily and azilsartan 40 mg, tablets, orally, once daily for up to 24 weeks.
Pioglitazone
Pioglitazone 45 mg, tablets, orally, once daily and azilsartan placebo-matching tablets, orally, once daily for up to 24 weeks.
Birmingham
Huntsville
Sierra Vista
Sun City
Tucson
Burbank
Escondido
Irvine
La Jolla
National City
Riverside
Sacramento
San Diego
Spring Valley
Coral Gables
DeLand
Hollywood
Miami
New Port Richey
Opa-locka
Pembroke Pines
Sarasota
Vero Beach
Atlanta
Augusta
Warner Robins
Honolulu
Lihue
Chicago
Dyersburg
Overland Park
Wichita
New Orleans
Shreveport
Salisbury
Cadillac
Detroit
Livonia
Kansas City
St Louis
Las Vegas
North Las Vegas
Berlin
Blackwood
Trenton
Albany
Kingston
Charlotte
Marion
Clinton
Oklahoma City
Allentown
Altoona
Philadelphia
Scotland
Woonsocket
Greer
Arlington
Dallas
Fort Worth
Midland
North Richard Hills
San Antonio
Renton
Buenos Aires
Córdoba
Rosario-Santa Fe
Santa Fe
Ushuaia - Tierre Del Fuego
Santiago
Aguascalientes
Cuernavaca
Durango
Guadalajara
Mexico City
Puebla City
Ica
Lima
Lead Sponsor
Takeda
INDUSTRY